NCT00149214 Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens Status COMPLETED Phase PHASE2
NCT00146588 Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer Status COMPLETED Phase NA
NCT00146562 Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer Status COMPLETED Phase PHASE2
NCT00144807 ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma Status COMPLETED Phase PHASE2
NCT00140595 ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1 Status COMPLETED Phase PHASE3
NCT00138229 Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma Status TERMINATED Phase PHASE2
NCT00136565 Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma Status COMPLETED Phase PHASE2
NCT00135499 R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma Status TERMINATED Phase PHASE3
NCT00134082 Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00134017 Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00134004 Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00133991 Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia Status COMPLETED Phase PHASE2
NCT00131963 A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel Status COMPLETED Phase N/A
NCT00131053 Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL) Status UNKNOWN Phase PHASE2
NCT00131027 High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL) Status UNKNOWN Phase PHASE3
NCT00130195 Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) Status COMPLETED Phase PHASE2
NCT00129935 EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer Status COMPLETED Phase PHASE3
NCT00129922 Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer Status COMPLETED Phase PHASE3
NCT00129389 FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients Status COMPLETED Phase PHASE3